Ned Milenkovich, PharmD, JD
This article is not intended as legal advice and should not be used as such. When legal questions arise, pharmacists should consult with attorneys familiar with the relevant drug and pharmacy laws. Ned Milenkovich is chair of the Healthcare Law practice at Much Shelist PC and vice chair of the Illinois State Board of Pharmacy. Contact him at: 312-521-2482 / [email protected]
Jury awards Walmart pharmacist more than $31 million
Sex discrimination and harassment were key elements of the case against Walmart.
“Death with dignity” laws gain traction in several states
Five states legally recognize assisted suicide in the face of terminal illness. More are likely to follow.
Valeant business practices embroiled in controversy
Valeant may have hooked up with Walgreen, but it still has a lot to answer for.
EpiPen adoption in U.S. schools soars after passage of federal law
Before passage of this legislation, only four states mandated access to epinephrine in schools. Now nearly every state has passed such a law.
Medicare Part D: New MTM model emphasizes medication adherence
CMS will now offer payers enticements to increase patient med adherence under the existing MTM model. The Part D effort is specifically focused on stand-alone Part D plans.
HHS releases 340B Proposed Guidance
Some big changes to program policies are in the works.
Washington state to require pharmacies to stock Plan B
The Ninth Circuit Court has upheld a Washington state law requiring pharmacies to provide patients with all medications in a timely manner.
Denver area pharmacy draws penalty for HIPAA privacy violation
Note to pharmacies: Don't throw unshredded patient heath information into Dumpsters. Just don't.
Omnibus Guidelines expected to bring changes to the 340B program
The 2015 guidelines are expected to clarify many current ambiguities.
First biosimilar finally approved by FDA
The approval of the first biosimilar heralds a new era in U.S. healthcare. But the rules for biosimilar use are not quite ready for prime time.